Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 230

    The Indian CEO driving change

    Ankit Gupta

    / Tenshi Kaizen & InstaPill

    Explore India’s evolving pharma landscape with Ankit Gupta, CEO at Tenshi Kaizen, as he shares insights on drug delivery innovation, CDMO growth, and strategic leadership in biopharma.

  • Episode 229

    40 years, 6 exits – a CEO addict

    Adam Sherlock

    / Qinecsa

    Explore the journey of Adam Sherlock, CEO at Qinecsa, as he shares insights on M&A, leadership, and the future of R&D.

  • Episode 228

    CDMO Live rewind: Industry leaders on the future of pharma

    Raman Sehgal, Gil Roth, Dr. Jim Li, Kaan-Fabian Kekec

    / Molecule to Market, PBOA, BioDuro-Sundia, Simon-Kucher

    Panel insights from CDMO Live 2025: Experts discuss funding strain, pricing shifts, global trade impact, and future-proofing strategies for pharma outsourcing.

  • Episode 227

    The learning curve of a biotech founder/CSO

    Hella Kohlhof

    / Immunic Therapeutics

    Join Immunic CSO Dr. Hella Kohlhof as she shares biotech insights on global outsourcing, Nasdaq growth, and scientific leadership.

  • Episode 226

    The cancer Doc, driven by impact

    Tim Showalter

    / ArteraAI

    Explore how Dr. Tim Showalter, Radiation Oncologist and CMO at ArteraAI, is transforming prostate cancer care with AI-powered diagnostics.

  • Episode 225

    The GM focused on inhaled & nasal drugs

    Gemma Budd

    / Nanopharm

    Gemma Budd, GM at Nanopharm, shares insights on inhalation drug delivery, CRO leadership, and driving pharmaceutical innovation in nasal and pulmonary therapies.

  • Episode 224

    The impact of a CEO who loves to work

    Jeanne Taylor Hecht

    / Lexitas

    Meet Jeanne Lexitas CEO & Chairwoman, biotech board leader, ophthalmology CRO specialist, and global pharma advisor passionate about patient-focused innovation.

  • Episode 223

    From brink of bankruptcy to boom

    Garren Hillow

    / Executive coach & author

    Discover how biotech entrepreneur Garren Hilow built and sold Abveris for $190M without VC funding. A must-listen for life science founders seeking scalable, founder-friendly growth.

  • Episode 222

    The CEO addicted to challenge

    Angelo Gatto

    / Chanelle Pharma

    Discover Angelo Gatto’s journey from Big Pharma to CEO of Chanelle Pharma, driving growth in CDMO and animal health innovation.

  • Episode 221

    The COO leveraging the ‘power of we’

    Christiane Bardroff

    / Rentschler Biopharma SE

    Hear from Christiane Bardroff, COO of Rentschler Biopharma, as she shares insights on biologics, leadership, and scaling global operations.

  • Load more